Tag: Dr. Michael Roshon

Ampio Pharmaceuticals begins phase 1 trial of Ampion for COVID-19 treatment

pharmanewsdaily- July 23, 2020

Ampio Pharmaceuticals has started a phase 1 clinical trial in the US for assessing its immunomodulatory anti-inflammatory agent Ampion as a five-day intravenous (IV) treatment ... Read More